An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

Clinical trial NCT05757570 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05757570
Sponsor: Alpine Immune Sciences, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia Idiopathic Thrombocytopenic Purpura Warm Autoimmune Hemolytic Anemia Cold Agglutinin Disease

Start date: 2023-07-03
Primary completion: 2026-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.